"Returning what we received": Neuromeka CEO Park Jong-hoon donates ₩5B to POSTECH's 'second founding'
Predicted impact: Low
Neuromeka뉴로메카
348340 · KOSDAQ · ₩348340 · 뉴로메카
₩18,040▲ ₩1,150 (6.81%)End-of-day · Oct 28, 2026 · End-of-day prices.
Price · 1Y +1.42%
- Market cap
- ₩422B
- Enterprise value
- ₩460B
- P/E
- —
- P/B
- 11.6×
- Dividend yield
- 0.0%
- ROE
- −110.4%
- Net margin
- −221.2%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−79.6% from the high
₩14,700Today: ₩17,000 – ₩18,250₩88,300
Returns
- 1W+1.0%
- 1M−10.9%
- 3M+13.2%
- 6M−56.8%
- YTD−13.7%
- 1Y+1.4%
- Volume today
- 227,123
- 0.8× the 20-day average
- Traded today
- ₩4.1B
- Listed shares
- 23,408,424
- EPS (12 months)
- −₩1,715
- Earnings yield −9.5%
AI researchResearch being writtenOur AI is writing a report on this company from filed data, prices and news. Check back soon.
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Why is it moving?
+6.8% on Oct 28, 2026.
Neuromeka's CEO Park Jong-hoon has donated 5 billion won to POSTECH, a Korean university, for its 'second founding' effort. A filing also reports a holding of more than 5% in the company.
AI summary of the news and filings linked. It can be wrong; check them.
- • Foreign investors bought a net ₩987M that day
Possible reasons, not certainties. Not financial advice.
Signals
Quiet- BuzzQuietBuzz 38 of 100 (50 is a normal day for this stock).
- SentimentPositiveNews: The headline covers a charitable donation by the CEO, which reads as mildly positive; the filing is routine. Community: 0 bullish, 0 bearish posts this week.
- MomentumWeak-10% over the last month; the price is below its 20-day average.
- News impactLow3 news items and filings in two weeks; 0 rated high impact, 0 medium.
Signals describe activity, not recommendations. Not financial advice.
Neuromeka stock overview
Neuromeka (뉴로메카, KRX: 348340) is listed on KOSDAQ, in the Machinery sector. The company develops and manufactures collaborative robots and related robot components, including actuators, reducers, motors, controllers and robot software, and also builds industrial automation solutions. Its shares closed at ₩18,040 on Oct 28, 2026, up 6.81% on the day, giving it a market value of ₩422B.
Key facts
- Market cap
- ₩422B
- Sector
- Machinery
- Latest price change
- +6.81%
- As of
- Oct 28, 2026
- Main business
- The company develops and manufactures collaborative robots and related robot components, including actuators, reducers, motors, controllers and robot software, and also builds industrial automation solutions.
Quick answers about Neuromeka
- What does Neuromeka do?
- The company develops and manufactures collaborative robots and related robot components, including actuators, reducers, motors, controllers and robot software, and also builds industrial automation solutions. Its products include humanoid, collaborative, mobile and industrial robots, with main sales to manufacturers and food and beverage companies, and it has production sites in Pohang and Changwon, South Korea, plus overseas subsidiaries in China, Vietnam and the United States.
- What is the market cap of Neuromeka?
- The market capitalisation of Neuromeka was ₩422B at the close on Oct 28, 2026.
- Who are the largest shareholders of Neuromeka?
- According to the latest official filings, the largest reported holders are Park Jong-hoon (14.98%, as of Oct 26, 2026); Mirae Asset Global Investors (6.25%, as of Sep 1, 2026); Samsung Asset Management (5.67%, as of Aug 10, 2026).
- When is the next earnings report from Neuromeka?
- Korean companies rarely announce results dates in advance. Based on when Neuromeka filed the same report in past years, its next 3q results is expected between Nov 14, 2026 and Nov 29, 2026.
- Does the National Pension Service own Neuromeka?
- Yes. The National Pension Service held 0.29% of Neuromeka shares as of Dec 31, 2023.
Company profile
The company develops and manufactures collaborative robots and related robot components, including actuators, reducers, motors, controllers and robot software, and also builds industrial automation solutions. Its products include humanoid, collaborative, mobile and industrial robots, with main sales to manufacturers and food and beverage companies, and it has production sites in Pohang and Changwon, South Korea, plus overseas subsidiaries in China, Vietnam and the United States.
Written by AI from the company's latest annual report.
- Korean name
- 뉴로메카
- Sector
- Machinery
- Themes
- Robots & humanoids
- CEO
- 박종훈
- Founded
- Feb 2013
- Listed
- Nov 2022
- Listed shares
- 23,408,424
- Fiscal year ends
- Month 12
- Website
- www.neuromeka.com
Similar companies
- Doosan Enerbility034020 · ₩39T₩61,400+4.24%
- Hanmi Semiconductor042700 · ₩19T₩203,500+6.32%
- Jusung Engineering036930 · ₩8.6T₩185,500+6.12%
- Rainbow Robotics277810 · ₩7.8T₩404,500+15.08%
- EO Technics039030 · ₩5.2T₩418,500+5.95%
- Wonik IPS240810 · ₩4.9T₩99,500+6.08%
- Doosan Bobcat241560 · ₩4.7T₩49,450+1.64%
- PSK Holdings031980 · ₩4.2T₩193,000+14.07%
Recent news
2027 TechQuest: Park Jong-hoon, CEO of Neuromeka, speaks at the event [Photo]
Predicted impact: Low
[Stock of the Day] Earnings rebound: Tirobotics · Physical AI Neuromeka in focus
Predicted impact: Low· Actual: +11.6% vs sector, volume 0.9× normal (5 trading days)
Earnings rebound mentioned in a stock pick article; no specific results or figures given.
Recent filings
See all- 5%+ holding reportOct 26, 2026
- Major sales or supply contractOct 1, 2026
- Insider shareholding reportSep 14, 2026
- 5%+ holding reportSep 1, 2026
- Half-year report (Jun 2026)Aug 14, 2026
Titles in Korean until English translations are added.
Also known as: Neuromeka / 뉴로메카 / 348340 / KRX:348340
Source: KRX statistical information